Pros
-Extraordinarily positive corporate culture. CEO takes highly functional team dynamics seriously. -Often cited leadership traits of honesty, competency, being forward looking and being inspirational are all in evidence with current CEO who started in 2020 -Late stage randomized clinical trials completely enrolled. Also an early clinical asset. -Professional capability in place at all levels of the company. -Transparency and accountability are embedded in leaderships actions -Recently increased emphasis on underlying biology and discovery work -Evidence of opportunities for career advancement provided to employees
Cons
-Stock price has been hammered since the IPO. But that could translate to more upside for those joining the company now.